Email This Article
Headlines & Perspectives
Single Drugmakers Seek Rich Partners
By
Adam Feuerstein
12/08/08 - 09:55 AM EST
Scores of smaller biotech firms have unpartnered drugs in the pipeline, making them ripe for alliances or takeovers.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.00 | 1,107.93 | 2,201.05 | 36.03 |
Oil *
72.08
|
|
DOWN
49.05
|
DOWN
6.18
|
DOWN
11.05
|
UP
0.57
|
10 Yr
3.60%
SPDR Gold
110.21
|
|
-0.47%
|
-0.55%
|
-0.50%
|
+1.61%
|
Data delayed 20 minutes |


Connect with TheStreet